Dabigatran vs Tofacitinib

## Dabigatran vs Tofacitinib: Overview

This comparison examines the pharmacological differences between **Dabigatran** and **Tofacitinib**.

## Mechanism of Action

**Dabigatran**: Direct thrombin (Factor IIa) inhibitor.

**Tofacitinib**: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

## Pharmacokinetics

**Half-life**: Dabigatran — 12-17 hours; Tofacitinib — 3.2 hours.

## Chemical Properties

**Molecular Formula**: Dabigatran — C25H25N7O3; Tofacitinib — C16H20N6O.

**Molecular Weight**: Dabigatran — 471.5100 g/mol; Tofacitinib — 312.3700 g/mol.

**Type**: Dabigatran — Small molecule; Tofacitinib — Small molecule.